Litcius/Paper detail

Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study

Luciana Muniz Pechmann, Thaísa Hoffmann Jonasson, V. S. Canossa, Heloísa Trierweiler, Gabrielle Kisielewicz, Ricardo Rasmussen Petterle, Carolina Aguiar Moreira, Victória Zeghbi Cochenski Borba

2020International Journal of Endocrinology54 citationsDOIOpen Access PDF

Abstract

Background. The aim of this study was to compare the prevalence of low muscle mass and sarcopenia in patients with type 2 diabetes mellitus (T2DM) versus paired controls (control group, CG) and the association between sarcopenia and chronic diabetes complications. Methods. Men and women ≥50 years with T2DM (T2DM group, T2DMG) were recruited during routine outpatient visits. Total body densitometry and handgrip strength (HGS) were evaluated in the T2DMG and CG, while the T2DMG was also evaluated for the physical performance using the gait speed (GS) test. Sarcopenia was diagnosed according to the criteria of the Foundation for the National Institutes of Health Sarcopenia Project (FNIH). Results. The study included 177 individuals in the T2DMG and 146 in the CG. The mean HGS value was lower in the T2DMG (24.4 ± 10.3 kg) compared with the CG (30.9 ± 9.15 kg), <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>p</a:mi> <a:mo>&lt;</a:mo> <a:mn>0.001</a:mn> </a:math> , with low HGS in 46 (25.9%) and 10 (9%) in the T2DMG and CG, respectively ( <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>p</c:mi> <c:mo>&lt;</c:mo> <c:mn>0.001</c:mn> </c:math> ). The prevalence of sarcopenia defined according to the FNIH criteria was higher in the T2DMG 23 (12.9%) compared with the CG 8 (5.4%), <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>p</e:mi> <e:mo>&lt;</e:mo> <e:mn>0.03</e:mn> </e:math> . The presence of albuminuria increased the odds of sarcopenia (odds ratio (OR) 2.84, 95% confidence interval (CI) 1.07–7.68, <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"> <g:mi>p</g:mi> <g:mo>=</g:mo> <g:mn>0.04</g:mn> </g:math> ) and osteoporosis (OR 3.38, 95% CI 1.12–9.89, <i:math xmlns:i="http://www.w3.org/1998/Math/MathML" id="M5"> <i:mi>p</i:mi> <i:mo>=</i:mo> <i:mn>0.03</i:mn> </i:math> ), even in patients with mild to moderate nephropathy. The body composition analysis showed increased odds of sarcopenia with increased percentage of total fat (%TF) in women (OR 1.18, 95% CI, 1.03–1.43, <k:math xmlns:k="http://www.w3.org/1998/Math/MathML" id="M6"> <k:mi>p</k:mi> <k:mo>=</k:mo> <k:mn>0.03</k:mn> </k:math> ) and men (OR 1.31, 95% CI, 1.10–1.75, <m:math xmlns:m="http://www.w3.org/1998/Math/MathML" id="M7"> <m:mi>p</m:mi> <m:mo>=</m:mo> <m:mn>0.01</m:mn> </m:math> ). Conclusion. Patients with T2DM presenting with albuminuria, osteoporosis, and increased %TF were more likely to have sarcopenia. This finding emphasizes the need for patients with T2DM to be evaluated for sarcopenia to allow for early implementation of measures to prevent or treat this disorder.

Topics & Concepts

SarcopeniaMedicineDiabetes mellitusInternal medicineType 2 Diabetes MellitusObservational studyCross-sectional studyType 2 diabetesPhysical therapyEndocrinologyPathologyNutrition and Health in AgingBody Composition Measurement TechniquesMuscle Physiology and Disorders
Sarcopenia in Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study | Litcius